凝原药的合成及其封装成聚合物纳米粒子,以提高治疗效率
Kajal Kaliya1,2, Neha Bhardwaj1,2, Ruchika1,2
1Formulation Laboratory, Dietetics and Nutrition Technology Division, CSIR-Institute of Himalayan Bioresource Technology, Palampur, Himachal Pradesh, 176061, India.
ChemMedChem
|January 8, 2025
概括
吉姆西塔 (GEM) 被修改成新的前期药物,4Dec-GEM显示出承诺. 在纳米颗粒中封装4Dec-GEM增强了其抗癌活性,这表明癌症治疗的强效组合疗法.
科学领域:
- * 制药化学 制药化学
- * 纳米技术的使用
- * 癌症生物学 癌症生物学
背景情况:
- * 葛西他 (GEM) 是一种重要的化疗剂,用于治疗各种癌症.
- *其临床实用性受到短半衰期和快速酶降解的限制.
- *需要新的策略来改善GEM的治疗指数.
研究的目的:
- *通过将GEM与不同脂肪酸结合,合成新的GEM前药物.
- * 评估这些GEM合物的体外抗癌潜力.
- *通过纳米粒子配方来增强一个有前途的结合剂 (4Dec-GEM) 的疗效.
主要方法:
- * 5种GEM脂肪酸结合物的合成和表征.
- *使用CCK-8试验进行体外细胞毒性评估.
- * 机理学研究包括亡,ROS生成和线粒体潜力.
- * 4Dec-GEM装载的PLGA纳米粒子的配方和特征.
- *纳米颗粒与原生GEM的比较细胞毒性评估.
主要成果:
- *成功合成了五种新的GEM合物.
- *4Dec-GEM表现出与原生GEM相比较的细胞毒性活性.
- * 4Dec-GEM的纳米粒子配方显著改善了癌症细胞系中的抗癌疗效.
- * 机理学研究为4Dec-GEM的作用模式提供了洞察力.
结论:
- *将GEM与脂肪酸,特别是4-decenoic酸结合在一起,可以产生有前途的前药物.
- *PLGA纳米粒子封装的4Dec-GEM增强了它的治疗潜力.
- * 前药-纳米粒子组合策略提供了一种有希望的方法来提高GEM的抗癌疗效.
相关概念视频
01:23Factors Affecting Dissolution: Particle Size and Effective Surface Area
Dissolution kinetics, an essential aspect of oral drug delivery, is significantly influenced by the drug's particle size. According to the Noyes-Whitney dissolution model, the dissolution rate correlates directly with the drug's surface area. The larger the surface area, the higher the drug's solubility in water, leading to a faster drug dissolution rate. Reducing particle size increases the effective surface area, enhancing the dissolution process. Micronization and nanosizing are employed to...
01:16Bioavailability Enhancement: Drug Solubility Enhancement
Bioavailability is a critical factor in determining a drug's effectiveness. It refers to the proportion of a drug that enters the circulation when introduced into the body and is, as a result, able to have an active effect. Enhancing bioavailability is essential for drugs with poor solubility, as it can significantly impact their therapeutic efficacy. Various methods are employed to increase the solubility of drugs, thereby enhancing their bioavailability.Micronization and nanonization are...
01:05Bioavailability Enhancement: Drug Stability Enhancement and GI Retention
Improving a drug's stability in the gastrointestinal (GI) tract is paramount for enhancing its bioavailability and therapeutic effectiveness. Various strategies are employed to protect the drug from the harsh gastric milieu and to ensure its release and absorption at the desired site within the GI tract.Polymer coatings are one such method used to shield drugs from the stomach's acidic environment. By preventing premature drug release, these coatings improve the bioavailability of unstable...
01:27Drug Delivery Systems: Different Types
Conventional oral drug products, termed immediate-release (IR) formulations, are engineered to promptly release their active pharmaceutical ingredient (API) upon ingestion, typically in tablets or capsules. This rapid release often results in swift drug absorption and consequent pharmacodynamic effects, although the timing and intensity can vary depending on the drug's properties. Prodrugs within these formulations require metabolic conversion to activate their pharmacodynamic effects,...
01:24Site-Targeted Drug Delivery Systems: Polymeric Carriers
Polymeric carriers enhance targeted drug delivery by increasing efficacy while minimizing off-target effects. These carriers comprise a biodegradable polymeric backbone integrated with functional elements that enable targeting, improve physicochemical properties, and regulate drug release.Targeting MechanismsThe targeting ability of polymeric carriers is mediated by a homing device, which is a molecular recognition component designed to selectively bind to specific tissues or cells. Monoclonal...